Systematic review and meta-analysis: Oseltamivir and zanamivir have limited effect on symptoms and do not reduce hospitalisation or serious complications of influenza

Evidence-Based Medicine

Volumn 19, Issue 6, 2014, Pages 211-

  Ebell, Mark H ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR; ANTIVIRUS AGENT; ENZYME INHIBITOR; SIALIDASE;

ARTICLE; DISEASE DURATION; DRUG CAPSULE; EMBASE; EUROPEAN MEDICINES AGENCY; FOOD AND DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; INFLUENZA; INTENTION TO TREAT ANALYSIS; MEDICAL DOCUMENTATION; MEDLINE; NAUSEA; OBSERVATIONAL STUDY; PNEUMONIA; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAPID TEST; RESPIRATORY TRACT DISEASE; SELF REPORT; SYMPTOM; SYSTEMATIC REVIEW (TOPIC); VALIDITY; VOMITING; ANTAGONISTS AND INHIBITORS; INFLUENZA, HUMAN;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR; ZANAMIVIR;

EID: 84911429164     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebmed-2014-110033     Document Type: Article

References (3)

1. Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003;163:1667-72.
2. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011;53:277-9.
3. Ebell MH, Williamson M, Schofill J. Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract 2013;30:125-33.